Press "Enter" to skip to content

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday.

Also Read:   Novo Nordisk wins U.S. approval for first-of-its-kind oral diabetes drug